Genetic changes in the body of patients can indicate which drugs are more effective in chemotherapy for breast cancer, US researchers reported, according to an Internet publication for girls and women from 14 to 35 years old Pannochka. Net Scientists have found that patients with two copies of the SOD2 gene experienced major health problems after chemotherapy with cyclophosphamide as compared to the rest of the patients. The results of the study were published in the journal Clinical Cancer Research.

The study involved 588 patients from the US and Norway. Some subjects underwent chemotherapy.

It turned out that women who had one copy of the SOD2 gene were at increased risk of death, and women who carried two copies of the gene were at the highest risk of death from all participants in the study.

According to the researchers, based on the results of this study, it is possible to develop tests that will help determine which drugs will be most effective and safe for each patient individually, thereby increasing the effectiveness of treatment.

Medicinform. Net.

Keywords:.